
    
      Market evaluation protocol.

      This ease of use study involves the use of FDA 510(k) cleared hemodialyzers and will have no
      impact on the patient's routine dialysis therapy. This study is strictly aimed at obtaining
      feedback from the nursing and technical staff regarding the use of the Polyflux HD-C4 Small
      dialyzer. The dialysis nursing staff will complete ease of use assessments following routine
      dialysis therapy.
    
  